Impact BioMedical Inc. (IBO)
AMEX: IBO
· Real-Time Price · USD
0.58
0.01 (2.29%)
At close: Aug 15, 2025, 3:59 PM
0.56
-2.75%
After-hours: Aug 15, 2025, 07:32 PM EDT
Impact BioMedical Cash Flow Statement
Financials in CAD. Fiscal
year is
undefined.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.82K | -27.13M | 4.24M | -882K | -998K | -1.26M | -1.58K | -1.46K | -486.6K | -792.86K | -841.96K | -6.55M | -1.17M | -1.04M | -1.73M | -23.16K | -83.42K |
Depreciation & Amortization | 407.20 | 279K | 281K | 279K | 280K | 280K | 380.31 | 370.92 | 72.31K | 69.43K | 66.33K | 79.16K | 71.57K | 68.94K | 46.72K | 77.00 | 76.00 |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.7K | -2.6K | 97.58K | 121.95K | 40.08K | -47.11K | 788.62K | n/a | n/a |
Other Working Capital | 156.84 | 193K | -282K | -26K | -185K | 192K | -58.4 | 113.93 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.69K | 74.52K |
Other Non-Cash Items | 277.70 | 26.01M | -5.67M | -230K | 230K | n/a | 217.32 | 128.50 | 17.32K | 27.32K | n/a | 2.63M | -25 | -85 | 160.48K | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 210K | n/a | 2.71M | n/a | n/a | 25.00 | n/a | n/a |
Change in Working Capital | 156.84 | -412K | -139K | -63K | 6K | 548K | 69.27 | -10.6 | 199.11K | 8.11K | 227.62K | -702.36K | 297K | -98.12K | -4.23K | 13.85K | 70.23K |
Operating Cash Flow | -981 | -1.26M | -1.28M | -896K | -482K | -433K | -911 | -971 | -172.15K | -480.6K | -450.43K | -1.71M | -765.03K | -1.12M | -739.6K | -9.23K | -13.12K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.9 | -42.74K | -210.79K | -143.24K | -11.77K | -83.91K | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 618.01K | n/a | n/a | -2.67M | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 1K | 1K | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.93K | n/a | n/a |
Investing Cash Flow | n/a | n/a | 1K | 1K | n/a | 1K | n/a | -14.57 | -42.74K | -210.79K | -143.24K | 606.25K | -83.91K | 11.86K | -2.62M | n/a | n/a |
Debt Repayment | n/a | 587K | 224K | 895K | 483K | 232K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 3.73M | n/a | n/a | n/a | 1.18K | 988.25 | 380K | 182.25K | 583.22K | -21.89K | -21.85K | -10.99K | 1.34M | 2.87M | 2.03M |
Financial Cash Flow | n/a | 587K | 3.95M | 895K | 483K | 232K | 1.18K | 988.25 | 375.93K | 179.71K | 571.3K | -121.89K | -271.85K | -10.99K | 7.41M | 2.87M | 2.13M |
Net Cash Flow | -977 | -669K | 2.67M | n/a | 1K | -200K | 269.03 | n/a | 161.05K | -511.67K | -22.37K | -1.23M | -1.12M | -1.12M | 4.05M | 2.86M | 2.12M |
Free Cash Flow | -981 | -1.26M | -1.28M | -896K | -482K | -433K | -912 | -986 | -214.89K | -691.38K | -593.67K | -1.72M | -848.94K | -1.12M | -739.6K | -9.23K | -13.12K |